The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease.
Hosted on MSN
Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance
Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity ...
According to the Gallup National Health and Well-Being Index, 37% of U.S. adults now report obesity, down from 39.9% three ...
A health expert has warned that obesity remains a growing health crisis affecting millions in the country. Wednesday is World ...
AAP recommends a multimodal approach to childhood obesity, including lifestyle changes, pharmacotherapy, and bariatric surgery, emphasizing early intervention and expanded treatment access. Addressing ...
Canada is recognized globally for its world-leading obesity care guidelines — yet Canadians continue to struggle to access the very treatment plans we’ve developed. Meanwhile, the same model of care ...
Utilization of AOMs and MBS is low, with disparities based on race, education, and insurance coverage influencing treatment access. Insurance coverage significantly impacts treatment likelihood, with ...
This article is sponsored by Novo Nordisk Canada Inc. The content is for informational purposes only. It is not intended to ...
Please provide your email address to receive an email when new articles are posted on . Disordered eating and food addiction are rarely about food alone. A comprehensive treatment approach to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results